Covered recipient · General Payments record
CHARLES CHACHA MAROA BABERE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,178.17
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $418.19 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $77.65 | 4 |
| Medtronic, Inc. | $74.21 | 1 |
| Lilly USA, LLC | $73.25 | 4 |
| SANOFI-AVENTIS U.S. LLC | $47.91 | 2 |
| Novo Nordisk AS | $42.16 | 2 |
| ABBVIE INC. | $34.23 | 2 |
| PFIZER INC. | $33.29 | 1 |
| SHIELD THERAPEUTICS INC | $19.39 | 1 |
| Amgen Inc. | $16.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.74 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103259117 | CMS |
| ABBVIE INC. | $13.49 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103259119 | CMS |
| Amgen Inc. | $16.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117194686 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.50 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104213081 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.30 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105877881 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.15 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105650968 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.70 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105892722 | CMS |
| Lilly USA, LLC | $19.78 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136113274 | CMS |
| Lilly USA, LLC | $19.36 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136113276 | CMS |
| Lilly USA, LLC | $19.00 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136110560 | CMS |
| Lilly USA, LLC | $15.11 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136096563 | CMS |
| Medtronic, Inc. | $74.21 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119324469 | CMS |
| Novo Nordisk Inc | $22.58 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096846811 | CMS |
| Novo Nordisk Inc | $19.58 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097807384 | CMS |
| PFIZER INC. | $33.29 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130878964 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.14 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139777000 | CMS |
| SANOFI-AVENTIS U.S. LLC | $28.77 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139777012 | CMS |
| SHIELD THERAPEUTICS INC | $19.39 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116265 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.